The contribution of the central nucleus of the amygdala to individual differences in amphetamine-induced hyperactivity.
Rats classified as high responders (HR) based on their response to an inescapable novel environment self-administer more amphetamine and have greater amphetamine-induced sensitization than rats classified as low responders (LR). Recent research suggests that the central nucleus of the amygdala (ACe) contributes to the elevated self-administration in HR rats. Therefore, the current study examined the role of the ACe in the expression of both amphetamine-induced sensitization and conditioned hyperactivity in HR and LR rats. Male Sprague-Dawley rats were screened for their response to inescapable novelty and classified as HR or LR rats. Rats were implanted with bilateral cannulae into the ACe and received amphetamine (1.0 mg/kg, s.c.) or saline injections immediately prior to 1-h locomotor sessions. Following five training sessions, all rats received an infusion of muscimol (0.5 microg/0.5 microl) or phosphate buffered saline (PBS) followed by a saline injection to measure conditioned hyperactivity. HR rats displayed conditioned hyperactivity, while LR rats did not, suggesting that HR and LR rats differ in the expression of conditioned hyperactivity. While ACe inactivation attenuated the expression of conditioned hyperactivity, it did not differentially affect HR and LR rats. Following additional training and a 10-day rest period, all rats were then tested for amphetamine-induced sensitization (1.0 mg/kg) following an infusion of muscimol or PBS. Inactivation of the ACe attenuated the expression of sensitization only in HR rats. These results suggest the ACe contributes to the greater amphetamine sensitization in HR rats.
Cain
Mary E
ME
Department of Psychology, Kansas State University, Manhattan, KS 66506-5302, USA. mecain@ksu.edu
Coolon
Rosemary A
RA
Gill
Margaret J
MJ
D000661:Amphetamine / Q000008:administration & dosage*; D000679:Amygdala / Q000187:drug effects*; D000704:Analysis of Variance; D000818:Animals; D002404:Catheterization; D002491:Central Nervous System Agents / Q000008:administration & dosage; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D003213:Conditioning, Psychological / Q000187:drug effects; D005106:Exploratory Behavior; D008297:Male; D008845:Microinjections; D009043:Motor Activity / Q000187:drug effects*; D009118:Muscimol / Q000008:administration & dosage; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013045:Species Specificity
D002491:Central Nervous System Agents; D000697:Central Nervous System Stimulants; D009118:Muscimol; D000661:Amphetamine